ABVC Biopharma Files 8-K for Shareholder Votes & Exhibits
Ticker: ABVC · Form: 8-K · Filed: Jun 4, 2025 · CIK: 1173313
| Field | Detail |
|---|---|
| Company | Abvc Biopharma, Inc. (ABVC) |
| Form Type | 8-K |
| Filed Date | Jun 4, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, shareholder-vote, financial-statements
TL;DR
ABVC Bio filed an 8-K for shareholder votes and financial docs. Nothing major revealed yet.
AI Summary
ABVC Biopharma, Inc. filed an 8-K on June 3, 2025, to report on matters submitted to a vote of security holders and to file financial statements and exhibits. The filing does not contain specific details on the vote outcomes or the nature of the financial statements beyond their submission.
Why It Matters
This filing indicates that ABVC Biopharma has held or is reporting on a shareholder vote and is submitting financial documents, which are standard but necessary disclosures for public companies.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for submission of documents and reporting on shareholder votes, without immediate material new information.
Key Players & Entities
- ABVC BIOPHARMA, INC. (company) — Registrant
- June 3, 2025 (date) — Date of earliest event reported
- Nevada (jurisdiction) — State of incorporation
- 44370 Old Warm Springs Blvd. Fremont, CA 94538 (address) — Principal business address
FAQ
What specific matters were submitted to a vote of security holders?
The filing states that matters were submitted to a vote of security holders, but does not specify the nature of these matters.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on June 3, 2025.
What is the principal business address of ABVC Biopharma, Inc.?
The principal business address of ABVC Biopharma, Inc. is 44370 Old Warm Springs Blvd., Fremont, CA 94538.
What is the state of incorporation for ABVC Biopharma, Inc.?
ABVC Biopharma, Inc. is incorporated in Nevada.
What are the two main items reported in this 8-K filing?
This 8-K filing reports on the submission of matters to a vote of security holders and the filing of financial statements and exhibits.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 4, 2025 regarding ABVC BIOPHARMA, INC. (ABVC).